These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28630896)

  • 21. Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism.
    Bianchi A; Giampietro A; Tartaglione L; Chiloiro S; Gentilella R; Bima C; Anile C; Olivi A; Pontecorvi A; De Marinis L
    J Neuroendocrinol; 2019 Apr; 31(4):e12692. PubMed ID: 30712287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.
    Audí L; Carrascosa A; Esteban C; Fernández-Cancio M; Andaluz P; Yeste D; Espadero R; Granada ML; Wollmann H; Fryklund L;
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2709-15. PubMed ID: 18445665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.
    Carrascosa A; Esteban C; Espadero R; Fernández-Cancio M; Andaluz P; Clemente M; Audí L; Wollmann H; Fryklund L; Parodi L;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3281-6. PubMed ID: 16804042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.
    Carrascosa A; Audí L; Fernández-Cancio M; Esteban C; Andaluz P; Vilaró E; Clemente M; Yeste D; Albisu MA; Gussinyé M
    J Clin Endocrinol Metab; 2008 Mar; 93(3):764-70. PubMed ID: 18160465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions.
    Filopanti M; Giavoli C; Grottoli S; Bianchi A; De Marinis L; Ghigo E; Spada A
    J Endocrinol Invest; 2011 Dec; 34(11):861-8. PubMed ID: 22322534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I.
    Besson A; Salemi S; Eblé A; Joncourt F; Gallati S; Jorge AA; Mullis PE
    Eur J Endocrinol; 2004 May; 150(5):635-42. PubMed ID: 15132718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone receptor (GHR) gene polymorphism and Prader-Willi syndrome.
    Butler MG; Roberts J; Hayes J; Tan X; Manzardo AM
    Am J Med Genet A; 2013 Jul; 161A(7):1647-53. PubMed ID: 23696513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The growth hormone receptor (GHR) polymorphism in growth-retarded children with Cushing disease: lack of association with growth and measures of the somatotropic axis.
    Drori-Herishanu L; Lodish M; Verma S; Bimpaki E; Keil MF; Horvath A; Stratakis CA
    Horm Metab Res; 2010 Mar; 42(3):194-7. PubMed ID: 20013551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
    Tauber M; Ester W; Auriol F; Molinas C; Fauvel J; Caliebe J; Nugent T; Fryklund L; Ranke MB; Savage MO; Clark AJ; Johnston LB; Hokken-Koelega AC;
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
    Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
    Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly.
    Cinar N; Dagdelen S; Yorgun H; Canpolat U; Kabakçı G; Erbas T
    Pituitary; 2015 Feb; 18(1):116-25. PubMed ID: 24706164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly.
    Mercado M; González B; Sandoval C; Esquenazi Y; Mier F; Vargas G; de los Monteros AL; Sosa E
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3411-5. PubMed ID: 18611972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.
    Barbosa EJ; Palming J; Glad CA; Filipsson H; Koranyi J; Bengtsson BA; Carlsson LM; Boguszewski CL; Johannsson G
    J Clin Endocrinol Metab; 2009 Feb; 94(2):639-44. PubMed ID: 19050057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.
    Szmit-Domagalska J; Petriczko E; Drozdzynska M; Adler G; Horodnicka-Jozwa A; Ciechanowicz A; Walczak M
    Neuro Endocrinol Lett; 2016 Sep; 37(4):282-288. PubMed ID: 27857044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone receptor (GHR) exon 3 polymorphism status detection by dual-enzyme-linked immunosorbent assay (ELISA).
    Wan J; Atzmon G; Hwang D; Barzlai N; Kratzsch J; Cohen P
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E77-81. PubMed ID: 23162096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.
    Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K
    Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GH receptor d3 polymorphism in Dutch patients with MPHD and IGHD born small or appropriate for gestational age.
    de Graaff LC; Meyer S; Els C; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):930-4. PubMed ID: 18031312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
    Mericq V; Román R; Iñiguez G; Angel B; Salazar T; Avila A; Perez-Bravo F; Cassorla F
    Horm Res; 2007; 68(3):132-8. PubMed ID: 17347571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy.
    Adetunji OR; MacFarlane IA; Javadpour M; Alfirevic A; Pirmohamed M; Blair JC
    Eur J Endocrinol; 2009 Oct; 161(4):541-6. PubMed ID: 19605543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.